COSCIENS Biopharma Inc.
CSCI
$3.00
$0.072.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.33M | 13.76M | 16.39M | 27.80M | 27.80M |
| Total Receivables | 2.78M | 1.86M | 2.47M | 1.36M | 1.36M |
| Inventory | 1.82M | 2.46M | 2.69M | 3.06M | 3.06M |
| Prepaid Expenses | 1.91M | 1.42M | 1.70M | 4.00K | 4.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 657.00K | 860.00K | 726.00K | 990.00K | 990.00K |
| Total Current Assets | 16.50M | 20.35M | 23.98M | 33.21M | 33.21M |
|
|
|||||
| Total Current Assets | 16.50M | 20.35M | 23.98M | 33.21M | 33.21M |
| Net Property, Plant & Equipment | 10.92M | 10.66M | 10.97M | 11.50M | 11.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | 3.34M | 3.34M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 132.00K | 128.00K | 123.00K | 2.00M | 2.00M |
| Total Assets | 27.56M | 31.14M | 35.07M | 50.05M | 50.05M |
|
|
|||||
| Total Accounts Payable | 1.54M | 2.86M | 2.41M | 3.59M | 3.59M |
| Total Accrued Expenses | 1.53M | 1.90M | 2.37M | 2.26M | 2.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 209.00K | 253.00K | 271.00K | 407.00K | 407.00K |
| Total Finance Division Other Current Liabilities | 2.30M | 2.05M | 2.17M | 3.65M | 3.65M |
| Total Other Current Liabilities | 2.30M | 2.05M | 2.17M | 3.65M | 3.65M |
| Total Current Liabilities | 5.58M | 7.06M | 7.22M | 9.90M | 9.90M |
|
|
|||||
| Total Current Liabilities | 5.58M | 7.06M | 7.22M | 9.90M | 9.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.05M | 1.97M | 2.04M | 1.28M | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.83M | 11.97M | 12.65M | 12.64M | 12.64M |
| Total Liabilities | 20.46M | 21.00M | 21.91M | 23.82M | 23.82M |
|
|
|||||
| Common Stock & APIC | 22.60M | 22.50M | 22.49M | 22.00M | 22.00M |
| Retained Earnings | -17.23M | -14.66M | -12.11M | 1.53M | 1.53M |
| Treasury Stock & Other | 1.72M | 2.30M | 2.79M | 2.69M | 2.69M |
| Total Common Equity | 7.10M | 10.14M | 13.16M | 26.23M | 26.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.10M | 10.14M | 13.16M | 26.23M | 26.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.10M | 10.14M | 13.16M | 26.23M | 26.23M |
|
|
|||||